Sufyan S. Hussain

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

CGM Accuracy in a Fragmented Regulatory Landscape: A Commentary on Harmonisation and Recent Evidence.

CGM Accuracy in a Fragmented Regulatory Landscape: A Commentary on Harmonisation and Recent Evidence.

Journal: Diabetes, obesity & metabolism

Published: April 27, 2026

Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy.

Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy.

Journal: Nature medicine

Published: February 18, 2026

Dialysis meets devices: the use of automated insulin delivery in end stage kidney disease and haemodialysis.

Dialysis meets devices: the use of automated insulin delivery in end stage kidney disease and haemodialysis.

Journal: Expert review of endocrinology & metabolism

Published: February 02, 2026

Diabetes community calls for quality standards for continuous glucose monitoring devices.

Diabetes community calls for quality standards for continuous glucose monitoring devices.

Journal: The Lancet regional health. Europe

Published: December 12, 2025

Discordant real-world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter.

Discordant real-world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter.

Journal: Diabetes, obesity & metabolism

Published: December 03, 2025

An international consensus on screening and monitoring early-stage type 1 diabetes: A roadmap to European implementation.

An international consensus on screening and monitoring early-stage type 1 diabetes: A roadmap to European implementation.

Journal: Diabetes, obesity & metabolism

Published: November 05, 2025

Improving Time-in-Range in Type 1 Diabetes: Projecting the Clinical and Cost Implications of Automated Insulin Delivery.

Improving Time-in-Range in Type 1 Diabetes: Projecting the Clinical and Cost Implications of Automated Insulin Delivery.

Journal: Diabetes technology & therapeutics

Published: September 19, 2025

Hybrid closed-loop systems in UK type 1 diabetes care: National survey of healthcare professional awareness, confidence, and training needs.

Hybrid closed-loop systems in UK type 1 diabetes care: National survey of healthcare professional awareness, confidence, and training needs.

Journal: Diabetes, obesity & metabolism

Published: June 30, 2025

Fully closed-loop systems: can people with type 1 diabetes just do it? Insights from open-source systems.

Fully closed-loop systems: can people with type 1 diabetes just do it? Insights from open-source systems.

Journal: Diabetologia

Published: June 12, 2025

Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study.

Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study.

Journal: Diabetes technology & therapeutics

Published: May 30, 2025

Beyond the Trend Arrow: Potential Value of Artificial Intelligence-Supported Glucose Predictions for People with Type 1 Diabetes Using Continuous Glucose Monitoring Systems.

Beyond the Trend Arrow: Potential Value of Artificial Intelligence-Supported Glucose Predictions for People with Type 1 Diabetes Using Continuous Glucose Monitoring Systems.

Journal: Diabetes technology & therapeutics

Published: May 29, 2025

Using automated insulin delivery to address the clinical challenges of glycemic management in people with type 1 diabetes and kidney failure on maintenance hemodialysis.

Using automated insulin delivery to address the clinical challenges of glycemic management in people with type 1 diabetes and kidney failure on maintenance hemodialysis.

Journal: Journal of diabetes investigation

Published: May 27, 2025

Showing 1-12 of 66

Last Updated: 09/26/2026